Drug: RGH-896: chronic pain clinical trials
Registry records that list "Drug: RGH-896" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
3
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
3 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain NCT00838799 | Completed | Phase 2 | United States | Forest Laboratories | 2009-02 |
| Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain NCT00838799 | Completed | Phase 2 | United States | Forest Laboratories | 2009-02 |
| Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain NCT00838799 | Completed | Phase 2 | United States | Forest Laboratories | 2009-02 |
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.